Product information and disease descriptionPlace of product in therapyDisease descriptionBurden of hereditary angioedema
Economic impact of diagnostic testing
7 evidence topics · 6 sources
Genetic testing: cost and limited routine necessity
Medicare payment rates for complement antigen and functional assays
Functional C1 inhibitor assay as the single initial test and expected effect on diagnostic costs
“This approach involves performing only the C1-INH functional assay whenever this test is available and reliable, rather than following the traditional recommendation of conducting all 3 tests (C1-INH levels, C1-INH functional assay, and C4 level), potentially reducing diagnostic costs (Fig. 5).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“The C1-INH antigenic assay is widely available, simple to perform, and generally accessible.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Functional activity testing of C1-INH and genetic testing are both rarely available in low- and middle-income countries, and genetic testing is often expensive in high-income countries.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Genetic testing for hereditary angioedema with normal C1 inhibitor and cascade family testing
“We recommend genetic testing for HAE-nC1-INH in patients for whom there is high clinical suspicion of HAE and who have normal C1-INH functional assay results.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Cascade screening refers to the process of sequentially testing close blood relatives, beginning with first-degree relatives and extending to siblings, parents, and children when a family member is found to be affected.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“This approach helps reduce costs, improves management of currently asymptomatic but affected individuals, and alleviates anxiety for unaffected family members.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Cost of sequential biochemical and genetic testing and sample transport
“Firstly, the use of a series of multiple tests from the initial C4 and C1-INH levels, followed by C1-INH function, and in equivocal cases or suspected HAE-nC1INH, genetic tests, is considerably costly.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“In regions lacking local laboratory capacity, samples must be shipped to external reference centres, incurring further costs and diagnostic delays [37].” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“C1-INH protein is labile in vitro; unless testing is performed within hours, samples require on-site centrifugation and storage at − 20 °C, necessitating an expensive cold chain for transport [38, 39].” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Effect of cascade family screening on hereditary angioedema-related costs: prospective screening program
“Prospective data on clinical, psychological, and HAE-related outcomes were collected at baseline and 1-year follow-up.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Potential HAE relatives were screened through the CFS approach.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Of 179 relatives, 53% were contactable, 67% of whom consented to screening.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Twenty-nine patients (46%) were newly given the diagnosis of HAE; half were symptomatic at baseline (52%).” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“By extrapolation, CFS led to a reduction of at least HK $1,200 (US $153) in HAE-related costs per patient per year.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Screening using a greater than suggested C4 cutoff of 22.9 mg/dL yielded superior sensitivity (100%) and specificity (77%).” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote